PuraPharm Corp. Ltd. (HK:1498) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
PuraPharm Corp. Ltd. has announced a change in its auditor, replacing Ernst & Young with BDO Limited, due to more competitive proposals that promise enhanced corporate governance and cost-effectiveness. This shift follows EY’s resignation over a disagreement on audit fees for the upcoming fiscal year. The company assures that the transition will not impact its annual audit for FY2024.
For further insights into HK:1498 stock, check out TipRanks’ Stock Analysis page.